Observational study in New York adults finds stable vaccine protection against COVID-19 hospitalizations

An observational study examined COVID-19 vaccine effectiveness in adults in New York. The study did not report its sample size, follow-up duration, comparator group, or primary outcome. The intervention was COVID-19 vaccination, but specific vaccine types or dosing schedules were not detailed.

The main findings indicated that vaccine effectiveness against COVID-19-related hospitalizations was reported as stable. In contrast, vaccine effectiveness against new SARS-CoV-2 infections was reported to have declined. The study did not provide effect sizes, absolute case numbers, p-values, or confidence intervals for these outcomes, limiting quantitative interpretation.

No safety, tolerability, or adverse event data were reported. Key limitations include the observational design, which cannot establish causality, and the absence of reported quantitative measures of effect. The practice relevance was not reported. Given the lack of detailed data, these findings should be viewed as preliminary descriptive observations from a specific geographic region.